Current Opinion in Allergy and Clinical Immunology was launched in 2001. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of allergy and clinical immunology are divided into 14 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.
Amos Etzioni, MD is a Professor of Pediatrics and Immunology at the Faculty of Medicine, Technion in Haifa, Israel and is the Director of the Children's hospital at the Rambam Health Campus in Haifa, Israel. After finishing a residency in pediatrics in Haifa, he did a fellowship in immunology in Philadelphia, USA and upon his return in 1982 opened the first center for primary immunodeficiency in Israel. His main interest in the field of primary immunodeficiency (PID) is in the leukocyte adhesion molecules defects, in which he described two new conditions LAD II and III. He has published more than 200 papers and has written many reviews and chapters in books. He was invited as a speaker to numerous international meetings in the field of immunodeficiency. He is currently the President of the Israeli Immunology Society as well as the President of the European Society for Immunodeficiency (ESID).
Ramsay L. Fuleihan
Ramsay L. Fuleihan, MD, is Associate Professor at Northwestern University Feinberg School of Medicine, USA and an Attending Physician at the Ann & Robert H. Lurie Children's Hospital of Chicago, Illinois, USA, where he is also Director of Primary Immunodeficiency Clinical Services and Director of the Jeffrey Modell Foundation Diagnostic Center for Primary Immunodeficiencies. In addition, Dr Fuleihan is Associate Director of the Allergy and Clinical Immunology Training Program at the Northwestern University Feinberg School of Medicine. Dr Fuleihan received his medical degree at the American University of Beirut in Lebanon. He then trained in pediatrics at Duke University Medical Center in Durham, North Carolina, USA and in allergy and immunology at the Children's Hospital Boston at Harvard Medical School in Massachusetts, USA.
A Diplomate of the American Board of Allergy and Immunology, Dr Fuleihan is a member of several professional societies, including the American Academy of Allergy, Asthma and Immunology, the European Society for Immunodeficiencies, the Clinical Immunology Society, and the Society for Pediatric Research. He is a member of the steering committee of the US Immunodeficiency Network and a member of the Medical Advisory Committee of the Immune Deficiency Foundation.
Dr Passalacqua was born in Genoa in 1964. He graduated in 1990 from the Genoa University Medical School, Italy, and received specialty degrees in Allergy and in Respiratory Medicine in 1994 and 2002. Under the chairmanship of Prof. Giorgio Walter Canonica, he contributed to investigation into the mechanisms of allergic inflammation, the treatment of respiratory allergy and developed sublingual immunotherapy. Currently he is Professor of Respiratory Medicine and Allergy at the Respiratory Diseases Clinic of the University of Genoa. Dr Passalacqua has coauthored more than 200 publications in peer reviewed journals. He serves on the board of experts of Allergic Rhinitis and its Impact on Asthma (ARIA), and is co-Chairman of the immunotherapy committee of the World Allergy Organization.
Dr Robert Bush received his MD degree from West Virginia University, USA. After completing his residency in internal medicine and fellowship in allergy and immunology at the University of Wisconsin – Madison, USA, he joined the faculty. He is currently Professor (Emeritus) of Medicine and was the former Chief of Allergy at the William S Middleton VA Hospital, Madison, Wisconsin, USA. His research interests include sublingual immunotherapy, allergen characterization, fungal allergy, food allergy, and occupational asthma.